Feasibility and Usefulness of a Neuropsychological Telerehabilitation Program in Asymptomatic HIV Patients: Pilot Randomized Controlled Trial

Status: Withdrawn
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Currently 37.9 million people are living with human immunodeficiency virus (HIV) around the world (UNAIDS, 2018). Even with antiretroviral treatment (ART), the virus enters the central nervous system and can affect the following structures: amygdala, hippocampus, thalamus, parietal, frontal, temporal regions, orbitofrontal, cingulate, motor and sensory cortex; generating cognitive, behavioral and motor alterations, up to HIV-associated neurocognitive disorder (HAND) and occasionally HIV-associated dementia (HAD). Few clinical studies have been conducted using computerized cognitive rehabilitation programs to counteract neuropsychological alterations. The aim of this project is to explore the feasibility of a cognitive stimulation program (CSP) developed to strengthen cognitive domains identified as impaired through a neuropsychological assessment in asymptomatic HIV+ patients adherent to ART, with the purpose of improving their quality of life and mood disorder.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 45
Healthy Volunteers: f
View:

• Male or females with HIV

• Minimum primary education

• From 20 to 45 years old

• Normal or corrected vision and hearing

• Treatment adherence

Locations
Other Locations
Mexico
Condesa Iztapalapa Specialized Clinic
Mexico City
Time Frame
Start Date: 2022-05-16
Completion Date: 2024-05-30
Treatments
Experimental: Study group
Refers to the experimental group that will receive the cognitive stimulation program intervention.
Other: Waiting list control group
Will be the control group that remains without intervention until the study group completes the cognitive stimulation program and the subsequent neuropsychological assessment has been done. Once the intervention is completed with the study group, the same program will be applied to the control group.
Related Therapeutic Areas
Sponsors
Leads: Universidad Nacional Autonoma de Mexico

This content was sourced from clinicaltrials.gov